Primary Job Title Board of Directors Primary Organization Novo Holdings
Location Copenhagen, Hovedstaden, Denmark Regions European Union (EU), Nordic Countries, Scandinavia Gender Male
LinkedIn View on LinkedIn
Steen Riisgaard was born on 22 March 1951 and is a Danish national. He holds a MSc in Microbiology from the University of Copenhagen.
Steen Riisgaard was President and CEO of Novozymes A/S from the demerger from Novo Nordisk A/S in 2000 and until April 2013. He joined Novo Nordisk in 1979 in Enzymes Research & Development, and in
1982 he moved to Tokyo to start up an enzymes research & development unit in the Novo Nordisk subsidiary Novo Industri Japan Ltd. After his return to Denmark in 1985, he held a range of jobs in the company before he was promoted to Corporate Executive Vice President with special responsibility for Enzyme Business in 1989.
Prior to joining Novo Nordisk, he was a research fellow at the Serum Institute of Denmark and a research microbiologist at Foss Electric, Denmark.
Mr Riisgaard is Chairman of the Board of Directors of ALK-Abello A/S, Cowi A/S, Rockwool International A/S and Xellia Pharmaceuticals A/S. Furthermore, he is Chairman of WWF (the World Wildlife Fund) Denmark, Vice Chairman of the Boards of Egmont International Holding A/S and serves on the Board of the Novo Nordisk Foundation and of CAT Science Park A/S.
